ONLINE EVENT: Breast Cancer in Young Women: Fifth ESO-ESMO International Consensus Symposium

Due to the current situation with COVID-19 we have decided that BCY5 will be held online.
Please, find out the latest information about the online symposium on www.e-ESO.net.

Co-Chairs: O.Pagani, CH - S. Paluch-Shimon, IL
Scientific Committee: F. Cardoso, PT - N. Harbeck, DE - A.H. Partridge, US - F.A. Peccatori, IT - E. Senkus, PL


FOREWORD
Breast cancer in young women is a complex disease, occurring when these women are at the peak of their reproductive years, family life and careers. Being a somewhat rare disease, the optimal management of these patients is based on scientific data derived from clinical trials mostly conducted on older women. Many aspects of breast cancer in young women are therefore poorly understood (e.g. etiology and biology among others) and research is much needed in this field. In addition, young women have many years ahead of them to suffer the long-term effects of treatment and specific survivorship issues (fertility and job among others). The international health situation forced us to turn the in-person BREAST CANCER IN YOUNG WOMEN FIFTH INTERNATIONAL CONSENSUS SYMPOSIUM into a virtual event. It will be a challenging opportunity for updating the available evidence on this field and generating future research concepts and collaborations. We have done our best to design and build a virtual meeting able to keep the interactive, international, and collaborative spirit.
It will cover challenges and opportunities in different cultural and economic settings, follow-up care, guidelines, and challenges in the management of ABC in young women. It will also include a Consensus Session that will form the basis for a Consensus Guidelines manuscript to be published after the Symposium. We hope that you will decide to join us online and contribute to further develop the understanding and treatment of this disease.

Olivia Pagani
On behalf of the Co-Chair and the Scientific Committee Members


LEARNING OBJECTIVES
• In depth learning and update of the scientific and clinical aspects of breast cancer in young women
• Highlight the importance of multi-disciplinary management and discuss difficult clinical cases
• Focus on clinical research priorities and future perspectives, involving patients’ advocates in setting the agenda
• Participate in the discussion of consensus guidelines

MAIN TOPICS
• Biology
• World perspective in epidemiology and treatment
• Hereditary breast cancer
• Loco-regional therapy
• Systemic therapy
• Psychosocial aspects and survivorship

The Symposium is an ESO-ESMO joint event

INVITED FACULTY
Omalkhair Abulkhair, Specialized Medical Center, Oncology Dept., Riyadh, SA
Benjamin O. Anderson, University of Washington, Department of Surgery, Seattle, WA, US
Hatem A. Azim Jr., Monterrey Institute of Technology, Department of Internal Medicine, Monterrey, MX
Gabriella Bianchi Micheli, Senology Center of Southern Switzerland (CSSI), Oncology Dpt., Viganello, CH
Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Bone Marrow Transplant and Hematology Dpt., Belgrade, RS
Michal Braun, Shani Shaare Zedek Medical Centre, Jerusalem, IL
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, PT
Maria-João Cardoso, Champalimaud Foundation, Breast Unit, Lisbon, PT
Ellen Copson, University of Southampton, Somers Cancer Research Building, Southampton, GB
Giuseppe Curigliano, European Institute of Oncology / University of Milan, New Drugs for Innovative Therapies Div., Milan, IT
Nagi S. El Saghir, American University of Beirut Medical Center, Internal Medicine - Hematology Oncology Dpt., Beirut, LB
Alexandru Eniu, Riviera-Chablais Vaud-Valais, Interdisciplinary Oncology Service (SIC), Rennaz, CH
Teresa Ferreiro, Baby Beatles, Barcelona, ES
Judy Garber, Dana Farber Cancer Institute, Centre for Cancer Genetics and Prevention, Boston, MA, US
Karen Gelmon, BC Cancer Agency, Medical Oncology Dpt., Vancouver, CA
Oreste Davide Gentilini, San Raffaele Hospital, Breast Surgery Dpt., Milano, IT
Nadia Harbeck, University of Munich (LMU), Breast Centre, Dept. of Obstetrics and Gynaecology, Munich, DE
Bella Kaufman, Sheba Medical Center, Dept. of Oncology, Ramat Gan, IL
Sung-Bae Kim, University of Ulsan College of Medicine , Asan Medical Center, Songpa-gu Seoul , KR
Matteo Lambertini, San Martino Hospital / University of Genoa, Medical Oncology Department, Genoa, IT
Qiang Liu, Sun Yat-sen Memorial Hospital,Sun Yat-sen University, Breast Tumour Centre, Guangzhou, CN
Jennifer Merschdorf, Young Survival Coalition, Patient Advocacy Dpt., New York, US
Olivia Pagani, Oncology Institute of Southern Switzerland (IOSI), Breast Unit, Bellinzona, CH
Shani Paluch-Shimon, Shaare Zedek Medical Centre, Breast Cancer Dpt., Jerusalem, IL
Ann H. Partridge, Dana-Farber Cancer Institute, Breast Oncology Dpt. and Adult Survivorship Programme, New Bedford, US
Fedro Alessandro Peccatori, European Institute of Oncology, Dept. of Fertility and Procreation in Oncology, Milan, IT
Philip Poortmans, Saint Augustus University Campus, Radiotherapy Department, Wilrijk, BE
Giancarlo Pruneri, IRCCS National Cancer Institute (INT), Pathology Dpt., Milan, IT
Antonella Richetti, Cantonal Hospital (EOC), Radiation Oncology Dept., Bellinzona, CH
Elzbieta Senkus, Medical University of Gdansk, Dept. of Oncology and Radiotherapy, Gdansk, PL
Bhawna Sirohi, Max Institute of Cancer Care, Medical Oncology Dpt., New Delhi & Gurgaon, IN
Tanja Spanic, Europa Donna Slovenia, Patient Advocacy Dpt., Ljubljana, SI
Virpi Sulosaari, Turku University of Applied Sciences, Dept. of Nursing Science, Turku, FI
Sabine Van den Bosch, Ospedale Regionale Bellinzona e Valli, Senology Dpt., Bellinzona, CH
Ines Vaz-Luis, Gustave Roussy Institute, Medical Oncology Dpt., Villejuif, FR

ORGANISING SECRETARIAT

Organisation and Programme
Francesca Marangoni (1)
email: fmarangoni@eso.net
phone: +39 02 85464525

Faculty
Dolores Knupfer (2)
email: dknupfer@eso.net
phone: +41 91 8200952

Registrations
Corinne Hall (1)
email: chall@eso.net
phone: +41 91 8200958

(1) European School of Oncology, Via Turati 29, 20123 Milan, Italy
(2) European School of Oncology, Piazza Indipendenza 2, 6500 Bellinzona, Switzerland

OFFICIAL LANGUAGE
The official language will be English. No translation will be provided.

CME ACCREDITATION CERTIFICATES
Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be issued by email.
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and 12 CME credits have been granted to this event. The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.
12 ESMO-MORA credits have been granted by ESMO.

ESCO CREDITS



The Symposium enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the Symposium earns participants 9 ESCO credits.
Visit www.esco.org for information on how to join ESCO.

SOCIAL MEDIA
Tweet, network and follow updates using #BCYONLINE on Twitter, Facebook and Instagram.